High Risk of Fractures Within 7 Years of Diagnosis in Asian Patients With Inflammatory Bowel Diseases-Reference-Cited by-同舟云学术

High Risk of Fractures Within 7 Years of Diagnosis in Asian Patients With Inflammatory Bowel Diseases

Published:2021-06 Issue: Volume: Page:
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Ahn Hyung Jin,Kim Ye-Jee,Lee Ho-Su,Park Jin Hwa,Hwang Sung Wook,Yang Dong-Hoon,Ye Byong Duk,Byeon Jeong-Sik,Myung Seung-Jae,Yang Suk-Kyun,Kim Beom-Jun,Park Sang Hyoung^ORCID

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference37 articles.

1. Bone health in adrenal disorders;Kim;Endocrinol Metab (Seoul),2018

2. Secondary osteoporosis: pathophysiology and diagnosis;Emkey;Best Pract Res Clin Endocrinol Metab,2014

3. Improving the quality of care for inflammatory bowel disease;Ye;Intest Res,2019

4. Can vitamin D supplementation help control inflammation in inflammatory bowel disease beyond its classical role in bone health?;Hwang;Intest Res,2019

5. The effect of vitamin D administration on inflammatory markers in patients with inflammatory bowel disease;Jun;Intest Res,2019

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The predictive value of albumin to alkaline phosphatase ratio for vertebral refractures in postmenopausal women;Journal of Bone and Mineral Metabolism;2024-07-29

2. Risk of avascular necrosis in patients with inflammatory bowel disease: Insights from a nationwide cohort study and the impact of corticosteroid use;Digestive and Liver Disease;2024-07

3. Continuing or stopping 5‐aminosalicylates in patients with inflammatory bowel disease on anti‐TNF therapy: A nationwide population‐based study;Alimentary Pharmacology & Therapeutics;2024-06-12

4. Increased risk of fragility fractures in patients with primary biliary cholangitis;JBMR Plus;2024-04-19

5. Comparative risk of serious infections and tuberculosis in Korean patients with inflammatory bowel disease treated with non-anti-TNF biologics or anti-TNF-α agents: a nationwide population-based cohort study;Therapeutic Advances in Gastroenterology;2024-01